Focused on developing targeted therapies for rare diseases and cancer, the company is a clinical-stage biopharmaceutical firm with a pipeline centered on precision oncology and genetically defined conditions. Its lead programs include treatments for desmoid tumors and neurofibromatosis type 1–associ...
3 members of Congress have disclosed 7 trades in SpringWorks Therapeutics, Inc. (SWTX), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 3 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-07-02 | Josh Gottheimer | sell | $1K – $15K |
| 2025-07-01 | Gilbert Cisneros | sell | $15K – $50K |
| 2025-01-29 | Gilbert Cisneros | buy | $1K – $15K |
| 2024-07-19 | Josh Gottheimer | buy | $1K – $15K |
| 2024-06-18 | Josh Gottheimer | sell | $1K – $15K |
| 2024-05-09 | Josh Gottheimer | buy | $1K – $15K |
| 2022-12-12 | Christopher L. Jacobs | buy | $1K – $15K |